69 related articles for article (PubMed ID: 10072937)
1. Molecular modeling of interaction between delta opioid receptor and 3-methylfentanylisothiocyanate.
Rong SB; Jiang HL; Chi ZQ; Chen KX; Zhu YC; Ji RY
Zhongguo Yao Li Xue Bao; 1997 May; 18(3):219-24. PubMed ID: 10072937
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling of mu opioid receptor and receptor-ligand interaction.
Rong SB; Zhu YC; Jiang HL; Zhao SR; Wang QM; Chi ZQ; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):317-22. PubMed ID: 10072913
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling of mu opioid receptor and its interaction with ohmefentanyl.
Tang Y; Chen KX; Jiang HL; Wang ZX; Ji RY; Chi ZQ
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):156-60. PubMed ID: 9772668
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling on kappa opioid receptor and its interaction with nonpeptide kappa opioid agonists.
Liu DX; Jiang HL; Shen JS; Zhu WL; Zhao L; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):131-6. PubMed ID: 10437159
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 4-(N,N-diarylamino)piperidines with high selectivity to the delta-opioid receptor: a combined 3D-QSAR and ligand docking study.
Podlogar BL; Poda GI; Demeter DA; Zhang SP; Carson JR; Neilson LA; Reitz AB; Ferguson DM
Drug Des Discov; 2000; 17(1):34-50. PubMed ID: 10928448
[TBL] [Abstract][Full Text] [Related]
6. Building 3D-structural model of kappa opioid receptor and studying its interaction mechanism with dynorphin A(1-8).
Wan XH; Huang XQ; Zhou DH; Jiang HL; Chen KX; Chi ZQ
Acta Pharmacol Sin; 2000 Aug; 21(8):701-8. PubMed ID: 11501178
[TBL] [Abstract][Full Text] [Related]
7. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
Shenderovich MD; Liao S; Qian X; Hruby VJ
Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of interactions between tetrahydroprotoberberines and dopamine receptors.
Tang Y; Chen KX; Jiang HL; Jin GZ; Ji RY
Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):8-12. PubMed ID: 8737443
[TBL] [Abstract][Full Text] [Related]
9. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
Zhorov BS; Ananthanarayanan VS
Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling on solvent effect and interaction mechanism of fentanyl analogs to mu-opioid receptor.
Huang XQ; Jiang HL; Luo XM; Rong SB; Gu JD; Tan XJ; Zhu YC; Chen KX; Ji RY; Cao Y
Acta Pharmacol Sin; 2000 Jan; 21(1):46-54. PubMed ID: 11263247
[TBL] [Abstract][Full Text] [Related]
11. Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells.
Xie Z; Bhushan RG; Daniels DJ; Portoghese PS
Mol Pharmacol; 2005 Oct; 68(4):1079-86. PubMed ID: 16006595
[TBL] [Abstract][Full Text] [Related]
12. Interaction of p-fluorofentanyl on cloned human opioid receptors and exploration of the role of Trp-318 and His-319 in mu-opioid receptor selectivity.
Ulens C; Van Boven M; Daenens P; Tytgat J
J Pharmacol Exp Ther; 2000 Sep; 294(3):1024-33. PubMed ID: 10945855
[TBL] [Abstract][Full Text] [Related]
13. Irreversible binding of cis-(+)-3-methylfentanyl isothiocyanate to the delta opioid receptor and determination of its binding domain.
Zhu J; Yin J; Law PY; Claude PA; Rice KC; Evans CJ; Chen C; Yu L; Liu-Chen LY
J Biol Chem; 1996 Jan; 271(3):1430-4. PubMed ID: 8576134
[TBL] [Abstract][Full Text] [Related]
14. Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands.
Xu H; Lu YF; Partilla JS; Zheng QX; Wang JB; Brine GA; Carroll FI; Rice KC; Chen KX; Chi ZQ; Rothman RB
Synapse; 1999 Apr; 32(1):23-8. PubMed ID: 10188634
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR comparative molecular field analysis on delta opioid receptor agonist SNC80 and its analogs.
Peng Y; Keenan SM; Zhang Q; Welsh WJ
J Mol Graph Model; 2005 Sep; 24(1):25-33. PubMed ID: 15950508
[TBL] [Abstract][Full Text] [Related]
16. Complementarity of delta opioid ligand pharmacophore and receptor models.
Mosberg HI
Biopolymers; 1999; 51(6):426-39. PubMed ID: 10797231
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.
Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM
J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565
[TBL] [Abstract][Full Text] [Related]
18. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of sigma 1 receptor ligands: a model of binding conformational and electrostatic considerations.
Gund TM; Floyd J; Jung D
J Mol Graph Model; 2004 Jan; 22(3):221-30. PubMed ID: 14629980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
